增生性瘢痕和瘢痕疙瘩药物注射治疗进展  

Advances in the treatment of hypertrophic scar and keloid with dermojet injections of drugs

作　　者：陈卫[1] 杨蓉娅[1] 

机构地区：[1]北京军区总医院全军皮肤损伤修复研究所,100700

出　　处：《实用皮肤病学杂志》2014年第6期447-449,共3页Journal of Practical Dermatology

摘　　要：增生性瘢痕和瘢痕疙瘩有着不同的临床表现及预后,但均有组织修复和再生的调节机制出现障碍,从而导致创伤修复出现异常的纤维化的特点。临床上增生性瘢痕和瘢痕疙瘩不仅给患者带来面容损毁,且即使使用手术方法切除也易复发。药物局部注射广泛应用于增生性瘢痕和瘢痕疙瘩的治疗,其方法简单且疗效确切,在预防和早期治疗上有明显优势;在这方面研究进展也较快。该文主要就常用的注射治疗药物及研究现状进行综述。Although there are differences existed in clinical manifestations and prognosis, hypertrophic scars and keloids are generally characterized by abnormally proliferative scar tissue and leading to fibrosis and abnormal wound healing. In clinical, hyperplastic scar and keloid may cause disifgurement or dysfunction. Surgical removal of hypertrophic scar and keloids poses a high recurrence risk. The treatment of hypertrophic scar and keloid with dermojet injections of drugs was widely used, the method is simple and effective, and it has obvious advantages in the prevention and early treatment of the disease, progress in this area is also fast. This review focuses on dermojet injections therapy and research status.

关 键 词：增生性瘢痕 瘢痕疙瘩 注射治疗 

分 类 号：R622[医药卫生—整形外科]